Compare Stocks › ABBV vs MDT

AbbVie Inc. (ABBV) vs Medtronic plc (MDT): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. MDT is overvalued at $97, with an intrinsic value of $80 and a margin of safety of -20%. Of the two, MDT has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
MDT
Medtronic plc
$96.54

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
MDT
  • ★Gross margin of 65.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Each dollar of retained earnings has created $4.25 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
MDT

    Key Valuation Metrics

    Learn more →
    ABBV
    MDT
    Valuation
    N/A
    Free Cash Flow
    $5.41B
    N/A
    FCF Yield
    4.38%
    50.67
    Trailing P/E
    23.72
    18.24
    Forward P/E
    15.07
    Quality & Moat
    29.08%
    ROIC
    7.26%
    N/A
    ROE
    10.65%
    73.72%
    Gross Margin
    65.27%
    0.60
    PEG Ratio
    1.73
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    0.38
    N/A
    Interest Coverage
    N/A
    2.03
    Net Debt / EBITDA
    1.86
    2.35%
    Dividend Yield
    2.98%
    ABBV: 3Ties: 1MDT: 4
    ABBVMDT

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    MDT

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    MDT
    $6.22
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $2.25B
    Δ Market Cap
    +$13.96B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    71.5% Overvalued
    Price is 71.5% above estimated fair value
    Current Price: $294.89
    Fair Value: $172.00
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    MDT
    20.4% Overvalued
    Price is 20.4% above estimated fair value
    Current Price: $96.54
    Fair Value: $80.20
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    Requires positive FCF to compute implied growth rate.

    MDT

    What growth rate is the market pricing in at $97?

    +10.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +11.5%

    The market implies +10.4% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +11.5%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    MDT
    65/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    MDT
    -2.58
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
    No. of Institutional Holders5,303
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    MDT
    Insiders 0.3%Institutions 88.8%Retail & Other 10.9%
    No. of Institutional Holders2,955
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    MDT
    0
    Buys (3M)
    0
    Buys (12M)
    JELLISON WILLIAM R
    Director
    $462,750
    @ $92.55 · 2025-08-25
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    1
    Sells (3M)
    4
    Sells (12M)
    Total value (12M): $18.92M
    DONOGHOE NICHOLAS
    Officer
    $8.18M
    @ $250.00 · 2026-08-14
    PURDUE DAVID RYAN
    Officer
    $1.22M
    @ $233.56 · 2026-03-04
    SIATIS PERRY C.
    General Counsel
    $4.38M
    @ $234.39 · 2026-03-02
    SIATIS PERRY C.
    General Counsel
    $5.15M
    @ $230.00 · 2026-02-25
    SALEKI-GERHARDT AZITA
    Chief Operating Officer
    $8.41M
    @ $198.42 · 2025-08-12
    DONOGHOE NICHOLAS
    Officer
    $2.64M
    @ $198.51 · 2025-08-05
    STEWART JEFFREY RYAN
    Officer
    $12.36M
    @ $210.08 · 2025-03-31
    REENTS SCOTT T.
    Chief Financial Officer
    $3.75M
    @ $212.34 · 2025-03-14
    GONZALEZ RICHARD A
    Director
    $20.26M
    @ $205.45 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $4.47M
    @ $210.45 · 2025-03-03
    SIATIS PERRY C.
    General Counsel
    $5.82M
    @ $208.69 · 2025-03-03
    RICHMOND TIMOTHY J
    Officer
    $6.07M
    @ $202.90 · 2025-02-26
    BUCKBEE KEVIN K
    Officer
    $3.85M
    @ $203.41 · 2025-02-26
    SIATIS PERRY C.
    General Counsel
    $1.14M
    @ $197.90 · 2025-02-20
    BUCKBEE KEVIN K
    Officer
    $310,032
    @ $172.24 · 2024-12-16
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    MDT
    1
    Sells (3M)
    5
    Sells (12M)
    Total value (12M): $8.92M
    KIIL HARRY SKIP
    Officer
    $138,883
    @ $93.65 · 2026-09-16
    WALTER MATTHEW R.
    Officer
    $257,931
    @ $83.15 · 2026-07-08
    KIIL HARRY SKIP
    Officer
    $336,965
    @ $80.44 · 2026-06-08
    KIIL HARRY SKIP
    Officer
    $5.13M
    @ $97.71 · 2026-02-19
    SMITH GREGORY L
    Officer
    $3.06M
    @ $101.95 · 2025-11-19
    KIIL HARRY SKIP
    Officer
    $788,048
    @ $91.58 · 2025-09-03
    WALL BRETT A
    Officer
    $1.12M
    @ $90.00 · 2025-01-24
    WALL BRETT A
    Officer
    $792,038
    @ $80.41 · 2025-01-08
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(72/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    MDT
    FearGreed
    😐Neutral(56/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    ⚪Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
    MDT
    ⚪Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
    View ABBV Full AnalysisView MDT Full Analysis

    Frequently Asked Questions: ABBV vs MDT

    Is AbbVie Inc. or Medtronic plc more undervalued in 2026?▼

    Based on our discounted cash flow model, MDT trades at a -20.4% margin of safety (intrinsic value $80 vs. price $97), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

    Which stock has a wider economic moat, AbbVie Inc. or Medtronic plc?▼

    ABBV scores 82/100 (Wide moat), while MDT scores 65/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is AbbVie Inc. in financial distress?▼

    ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. MDT scores 3.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, AbbVie Inc. or Medtronic plc?▼

    ABBV earns 29.1% ROIC versus MDT's 7.3%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, AbbVie Inc.'s or Medtronic plc's?▼

    MDT's dividend earns a safety score of 49/100 (Borderline), compared to ABBV's 39/100 (Unsafe). MDT has raised its dividend for 3 consecutive years.

    ABBV vs MDT: Which Is the Better Buy in 2026? | SafetyMargin.io